Sunesis Pharmaceuticals (SNSS) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
General and administrative: 4M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
General and administrative: 4M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q4 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $670 thousand versus the consensus estimate of $700 thousand.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- Live Ventures (LIVE) Reports Q3 Loss of $0.34
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
